[PETDAG] QoQ Annualized Quarter Result on 31-Mar-2011 [#4]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
26-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2011
Quarter
31-Mar-2011 [#4]
Profit Trend
QoQ--%
YoY- 15.51%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
Revenue 22,267,793 35,627,688 45,239,562 23,267,648 0 22,513,312 21,905,570 1.31%
PBT 898,925 1,418,880 1,744,854 1,208,911 0 1,191,160 1,122,946 -16.28%
Tax -239,625 -371,911 -481,788 -332,984 0 -329,620 -305,858 -17.70%
NP 659,300 1,046,968 1,263,066 875,927 0 861,540 817,088 -15.74%
-
NP to SH 654,533 1,038,652 1,252,368 869,728 0 855,029 810,216 -15.66%
-
Tax Rate 26.66% 26.21% 27.61% 27.54% - 27.67% 27.24% -
Total Cost 21,608,493 34,580,719 43,976,496 22,391,721 0 21,651,772 21,088,482 1.96%
-
Net Worth 4,777,395 4,665,202 5,009,471 4,800,898 0 4,573,412 4,626,968 2.58%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
Div 794,577 714,669 894,548 993,974 - - 794,329 0.02%
Div Payout % 121.40% 68.81% 71.43% 114.29% - - 98.04% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
Net Worth 4,777,395 4,665,202 5,009,471 4,800,898 0 4,573,412 4,626,968 2.58%
NOSH 993,221 992,596 993,942 993,974 994,220 994,220 992,911 0.02%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
NP Margin 2.96% 2.94% 2.79% 3.76% 0.00% 3.83% 3.73% -
ROE 13.70% 22.26% 25.00% 18.12% 0.00% 18.70% 17.51% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
RPS 2,241.98 3,589.34 4,551.53 2,340.87 0.00 2,264.42 2,206.20 1.29%
EPS 65.90 104.64 126.00 87.50 0.00 86.00 81.60 -15.69%
DPS 80.00 72.00 90.00 100.00 0.00 0.00 80.00 0.00%
NAPS 4.81 4.70 5.04 4.83 0.00 4.60 4.66 2.56%
Adjusted Per Share Value based on latest NOSH - 993,286
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
RPS 2,241.45 3,586.24 4,553.77 2,342.10 0.00 2,266.17 2,204.99 1.31%
EPS 65.88 104.55 126.06 87.55 0.00 86.07 81.56 -15.67%
DPS 79.98 71.94 90.04 100.05 0.00 0.00 79.96 0.01%
NAPS 4.8089 4.6959 5.0425 4.8325 0.00 4.6035 4.6575 2.58%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/12/10 30/09/10 -
Price 17.80 15.96 16.10 16.50 11.70 11.70 11.00 -
P/RPS 0.79 0.44 0.35 0.70 0.00 0.52 0.50 44.10%
P/EPS 27.01 15.25 12.78 18.86 0.00 13.60 13.48 74.20%
EY 3.70 6.56 7.83 5.30 0.00 7.35 7.42 -42.63%
DY 4.49 4.51 5.59 6.06 0.00 0.00 7.27 -31.94%
P/NAPS 3.70 3.40 3.19 3.42 0.00 2.54 2.36 43.21%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 01/01/11 31/12/10 30/09/10 CAGR
Date 24/02/12 23/11/11 10/08/11 26/05/11 - 16/02/11 25/11/10 -
Price 18.00 16.36 16.54 16.30 0.00 12.50 11.12 -
P/RPS 0.80 0.46 0.36 0.70 0.00 0.55 0.50 45.55%
P/EPS 27.31 15.63 13.13 18.63 0.00 14.53 13.63 74.20%
EY 3.66 6.40 7.62 5.37 0.00 6.88 7.34 -42.63%
DY 4.44 4.40 5.44 6.13 0.00 0.00 7.19 -31.95%
P/NAPS 3.74 3.48 3.28 3.37 0.00 2.72 2.39 42.99%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment